Halozyme Therapeutics, Inc. (HALO)
105.32
-1.60
(-1.50%)
USD |
NASDAQ |
Aug 28, 16:00
104.89
-0.43
(-0.41%)
After-Hours: 20:00
Halozyme Therapeutics EPS Diluted (TTM) : 3.347 for June 30, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.347 |
| March 31, 2026 | 2.780 |
| December 31, 2025 | 2.492 |
| September 30, 2025 | 4.757 |
| June 30, 2025 | 4.378 |
| March 31, 2025 | 3.769 |
| December 31, 2024 | 3.433 |
| September 30, 2024 | 3.022 |
| June 30, 2024 | 2.580 |
| March 31, 2024 | 2.418 |
| December 31, 2023 | 2.109 |
| September 30, 2023 | 1.874 |
| June 30, 2023 | 1.706 |
| March 31, 2023 | 1.305 |
| December 31, 2022 | 1.444 |
| September 30, 2022 | 1.490 |
| June 30, 2022 | 2.524 |
| March 31, 2022 | 2.984 |
| December 31, 2021 | 2.747 |
| September 30, 2021 | 2.788 |
| June 30, 2021 | 1.566 |
| March 31, 2021 | 1.134 |
| December 31, 2020 | 0.9015 |
| September 30, 2020 | 0.1534 |
| June 30, 2020 | -0.2726 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.5602 |
| December 31, 2019 | -0.5035 |
| September 30, 2019 | -0.2743 |
| June 30, 2019 | -0.2966 |
| March 31, 2019 | -0.356 |
| December 31, 2018 | -0.5607 |
| September 30, 2018 | 0.304 |
| June 30, 2018 | 0.5175 |
| March 31, 2018 | 0.4475 |
| December 31, 2017 | 0.38 |
| September 30, 2017 | -0.68 |
| June 30, 2017 | -0.93 |
| March 31, 2017 | -0.91 |
| December 31, 2016 | -0.81 |
| September 30, 2016 | -0.57 |
| June 30, 2016 | -0.53 |
| March 31, 2016 | -0.30 |
| December 31, 2015 | -0.26 |
| September 30, 2015 | -0.33 |
| June 30, 2015 | -0.30 |
| March 31, 2015 | -0.45 |
| December 31, 2014 | -0.55 |
| September 30, 2014 | -0.70 |
| June 30, 2014 | -0.71 |
| March 31, 2014 | -0.78 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Incyte Corp. | 7.846 |
| AVITA Medical, Inc. | -1.444 |
| Neurocrine Biosciences, Inc. | 6.826 |
| Iovance Biotherapeutics, Inc. | -0.7214 |
| Editas Medicine, Inc. | -0.7446 |